Mainstreaming Genetic Testing for Adult Patients With Autosomal Dominant Polycystic Kidney Disease

Abstract

A MGT pathway using clearly defined criteria and commercially available gene panels for ADPKD can be successfully implemented in a publicly funded health care system to reduce the time required to obtain genetic results.